JP4452777B2 - 抗−感染物質としての多糖誘導体の使用 - Google Patents

抗−感染物質としての多糖誘導体の使用 Download PDF

Info

Publication number
JP4452777B2
JP4452777B2 JP2003557585A JP2003557585A JP4452777B2 JP 4452777 B2 JP4452777 B2 JP 4452777B2 JP 2003557585 A JP2003557585 A JP 2003557585A JP 2003557585 A JP2003557585 A JP 2003557585A JP 4452777 B2 JP4452777 B2 JP 4452777B2
Authority
JP
Japan
Prior art keywords
sub
group
alkyl
benzyl
polysaccharide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2003557585A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005519057A5 (enExample
JP2005519057A (ja
Inventor
ハアク，ベラ
ハインツエ，トマス
シユミトケ，ミヒヤエラ
メルマン，ウテ
ダーセ，ハンス−マルテイン
ヘルトル，アルベルト
Original Assignee
ダウ グローバル テクノロジーズ インコーポレイティド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ダウ グローバル テクノロジーズ インコーポレイティド filed Critical ダウ グローバル テクノロジーズ インコーポレイティド
Publication of JP2005519057A publication Critical patent/JP2005519057A/ja
Publication of JP2005519057A5 publication Critical patent/JP2005519057A5/ja
Application granted granted Critical
Publication of JP4452777B2 publication Critical patent/JP4452777B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/718—Starch or degraded starch, e.g. amylose, amylopectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/719—Pullulans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/721—Dextrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cosmetics (AREA)
JP2003557585A 2002-01-10 2003-01-10 抗−感染物質としての多糖誘導体の使用 Expired - Fee Related JP4452777B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10200717A DE10200717A1 (de) 2002-01-10 2002-01-10 Verwendung von Polysaccharid-Derivaten als antiinfektive Substanzen
PCT/DE2003/000095 WO2003057227A1 (de) 2002-01-10 2003-01-10 Verwendung von polysaccharid-derivaten als antiinfektive substanzen

Publications (3)

Publication Number Publication Date
JP2005519057A JP2005519057A (ja) 2005-06-30
JP2005519057A5 JP2005519057A5 (enExample) 2006-03-02
JP4452777B2 true JP4452777B2 (ja) 2010-04-21

Family

ID=7711838

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003557585A Expired - Fee Related JP4452777B2 (ja) 2002-01-10 2003-01-10 抗−感染物質としての多糖誘導体の使用

Country Status (17)

Country Link
US (1) US7297687B2 (enExample)
EP (1) EP1465640B8 (enExample)
JP (1) JP4452777B2 (enExample)
KR (1) KR100913301B1 (enExample)
CN (1) CN1615141B (enExample)
AT (1) ATE408411T1 (enExample)
AU (1) AU2003210125B2 (enExample)
BR (1) BRPI0306851A8 (enExample)
CA (1) CA2472586C (enExample)
DE (2) DE10200717A1 (enExample)
ES (1) ES2314205T3 (enExample)
MX (1) MXPA04006673A (enExample)
NO (1) NO20043265L (enExample)
PL (1) PL206600B1 (enExample)
RU (1) RU2332221C2 (enExample)
WO (1) WO2003057227A1 (enExample)
ZA (1) ZA200405400B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004110193A1 (en) * 2003-06-13 2004-12-23 Wadstroem Torkel Product for absorption purposes
CN100469707C (zh) * 2005-03-11 2009-03-18 中国石化北京燕化石油化工股份有限公司 一种高浊高铁循环冷却水的处理方法
KR101278106B1 (ko) * 2011-03-03 2013-06-24 이원실 이온성 액체를 이용한 셀룰로오스계 고분자 항균제의 제조방법
EP2822384A1 (de) 2012-03-09 2015-01-14 Friedrich-Schiller-Universität Jena Di- und multifunktional amin-modifizierte oligo- und polysaccharidderivate als antiinfektive substanzen und deren verwendung
US20170360040A1 (en) * 2014-12-02 2017-12-21 B.G. Negev Technologies And Applications Ltd., At Ben-Gurion University Modified polysaccharides for use as anti-microbial agents
FR3064473B1 (fr) * 2017-04-03 2021-02-12 Basf Beauty Care Solutions France Sas Ingredient protecteur de l'equilibre de la flore microbienne cutanee et/ou mucosale
CN112423771B (zh) * 2018-07-20 2023-05-09 株式会社资生堂 病毒灭活剂
CN115260320B (zh) * 2021-04-30 2023-05-05 中国科学院化学研究所 离子型多糖衍生物用作防冰涂层材料的应用
KR102559540B1 (ko) 2022-09-19 2023-07-25 문건희 토류벽시스템용 토류벽체

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60203265A (ja) * 1984-03-28 1985-10-14 ダイセル化学工業株式会社 抗血液凝固性高分子材料
DE3711680A1 (de) * 1987-04-07 1988-10-27 Hoechst Ag Waessrige biozide kationische kunststoffdispersionen und deren verwendung als fungizide, bakterizide und algizide ausruestungsmittel
DE3720555A1 (de) * 1987-06-22 1989-01-05 Henkel Kgaa Verwendung von unloeslichen, polyfunktionellen quartaeren ammoniumverbindungen zur adsorptiven bindung von mikroorganismen
IT1231168B (it) * 1989-07-21 1991-11-22 Texcontor Ets Copolimeri saccaridici aventi attivita' antibatterica.
JPH0457969A (ja) 1990-06-27 1992-02-25 Unitika Ltd 抗菌性布帛の製造方法
US5731259A (en) 1991-05-03 1998-03-24 Societa Consortile Ricerche Angelini S.P.A. Cationic polysaccharides
IT1249309B (it) * 1991-05-03 1995-02-22 Faricerca Spa Polisaccaridi di tipo cationico
GB2262531B (en) * 1991-12-17 1995-12-06 Erba Carlo Spa Antiviral sulphated polysaccharides
JPH05295002A (ja) * 1992-04-23 1993-11-09 Nichiden Kagaku Kk 抗菌性澱粉、水溶性多糖類及びその製造方法
ZA947572B (en) * 1993-09-29 1995-09-28 Hampton Roads Medical College Contraceptive compositions
RU2098114C1 (ru) * 1995-02-03 1997-12-10 Музыка Владислав Иванович Препарат, воздействующий на функциональную активность клеток эукариот и прокариот
JPH10155898A (ja) * 1996-11-26 1998-06-16 Toyobo Co Ltd 抗菌性付与抗血栓性材料
US6096291A (en) 1996-12-27 2000-08-01 Biovector Therapeutics, S.A. Mucosal administration of substances to mammals
US6306835B1 (en) * 1997-09-23 2001-10-23 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Biocidal chitosan derivatives
CA2268464A1 (en) * 1998-04-09 1999-10-09 National Starch And Chemical Investment Holding Corporation Nonionically derivatized starches and their use in non-aerosol, low voc hair cosmetic compositions
EP1141453A1 (en) * 1998-10-29 2001-10-10 Ciba SC Holding AG Incorporation of organic anti-microbials into fibres during a fibre spinning process

Also Published As

Publication number Publication date
CN1615141A (zh) 2005-05-11
JP2005519057A (ja) 2005-06-30
CA2472586C (en) 2011-03-15
EP1465640A1 (de) 2004-10-13
US20050054609A1 (en) 2005-03-10
BRPI0306851A8 (pt) 2017-04-25
EP1465640B1 (de) 2008-09-17
RU2332221C2 (ru) 2008-08-27
WO2003057227A1 (de) 2003-07-17
CA2472586A1 (en) 2003-07-17
BRPI0306851A2 (pt) 2016-11-16
ZA200405400B (en) 2005-11-30
AU2003210125A1 (en) 2003-07-24
KR20040079415A (ko) 2004-09-14
NO20043265L (no) 2004-08-04
MXPA04006673A (es) 2004-11-10
DE10200717A1 (de) 2003-07-31
EP1465640B8 (de) 2009-04-01
PL206600B1 (pl) 2010-08-31
AU2003210125B2 (en) 2008-01-24
PL370887A1 (en) 2005-05-30
ES2314205T3 (es) 2009-03-16
KR100913301B1 (ko) 2009-08-26
ATE408411T1 (de) 2008-10-15
US7297687B2 (en) 2007-11-20
DE50310510D1 (de) 2008-10-30
RU2004124389A (ru) 2005-05-10
CN1615141B (zh) 2013-08-14

Similar Documents

Publication Publication Date Title
AU642023B2 (en) Anti-virus agent
JP4452777B2 (ja) 抗−感染物質としての多糖誘導体の使用
US5322841A (en) Method for producing neutral glucans for pharmaceutical applications
EP2035338B1 (en) Method for producing a chitosan-arginine compound
CN101649007B (zh) 壳聚糖季磷盐衍生物及其制备方法
CN100518744C (zh) 一种抑菌护理用品
Je et al. Cytotoxic activities of water-soluble chitosan derivatives with different degree of deacetylation
de Carvalho et al. Quaternization of cassava starch and determination of antimicrobial activity against bacteria and coronavirus
Erum et al. Modified and unmodified arabinoxylans from Plantago ovata husk: Novel excipients with antimicrobial potential
Hussain et al. Preparation of chitosan oligomers and characterization: Their antifungal activities and decay resistance
Sosa‐Santillán et al. Synthesis, characterization, and antibacterial activities of novel starch derivatives against E. coli and S. aureus
JPH03167102A (ja) 抗菌剤
JPH0343401A (ja) 置換されたポリサツカライドおよびその製法
NZ533960A (en) Use of polysaccharide derivatives as anti-infective substances
HK1074795A (en) Use of polysaccharide derivatives as anti-infective substances
WO2013132061A1 (de) Di- und multifunktional amin-modifizierte oligo- und polysaccharidderivate als antiinfektive substanzen und deren verwendung
CN105582020A (zh) 一种线形聚硫脲和超支化聚硫脲在制备抗肿瘤药物及抗病毒或抗菌药物中的应用
Deng et al. Low-Cytotoxicity, Broad-Spectrum Corn Starch-Based Antibacterial Particles that Inhibit Multidrug-Resistant Bacteria
JP2997848B2 (ja) Ｎ―アセチルキトオリゴ糖とマイトマイシン類の複合体及び抗腫瘍剤
Padgaonkar et al. Polysaccharides as potential inhibitors targeting SARS-CoV-2
Alkadi et al. Review on the Importance of Chitosan in Different Pharmaceutical Applications
JP2003510283A (ja) 感染阻止のための陽性に荷電した炭水化物ポリマー
Duca et al. Cyclodextrins–fields of application. Part II
JPH01207215A (ja) レトロウイルス用抑制剤

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060106

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060106

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A712

Effective date: 20080702

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20090216

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090714

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20091013

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20091020

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20091111

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20091127

TRDD Decision of grant or rejection written
RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20091201

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20091208

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20091214

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20091203

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130212

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130212

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140212

Year of fee payment: 4

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees